• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SNT

SYNTARA LIMITED

1.96% ! 2.5¢
Market Cap $40.80M  !

Syntara Limited is an Australia-based clinical-stage drug development company. The... Syntara Limited is an Australia-based clinical-stage drug development company. The Company is targeting extracellular matrix dysfunction with its amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The Company’s lead candidate SNT-5505 is for the bone marrow cancer myelofibrosis which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its product candidate, SNT-4728, is an inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis and cardiac fibrosis.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SNT
Draft Motion to Remove CEO
17:11 4 247
17:11 Last post  BioMetrics Comments Created with Sketch.  4  Views Created with Sketch.  247 
SNT
Accountability
05:42 10 1.4K
05:42 Last post  newB Comments Created with Sketch.  10  Views Created with Sketch.  1.4K 
SNT
Value of Syntara
4 5 6
05/09/25 340 102K
05/09/25 Last post  dc1234 Comments Created with Sketch.  340  Views Created with Sketch.  102K 
SNT 02/09/25 16 2.4K
02/09/25 Last post  PJCCopper Comments Created with Sketch.  16  Views Created with Sketch.  2.4K 
SNT 29/08/25 3 647
29/08/25 Last post  NZ Trader Comments Created with Sketch.  3  Views Created with Sketch.  647 
SNT 29/08/25 1 310
29/08/25 Last post  NZ Trader Comments Created with Sketch.  1  Views Created with Sketch.  310 
SNT 29/08/25 1 305
29/08/25 Last post  NZ Trader Comments Created with Sketch.  1  Views Created with Sketch.  305 
SNT 28/08/25 0 138
28/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  138 

See All Discussions arrow Created with Sketch.

Timeline

Letter to shareholders - path forward for amsulostat
01 Sep 08:43
 
2025 Corporate Governance Statement
28 Aug 14:23
 
Appendix 4G Key to Disclosures
28 Aug 14:21
 
Annual Report to shareholders
28 Aug 14:05
 
Preliminary Final Report
28 Aug 13:55
 
Application for quotation of securities - SNT
28 Aug 10:32
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
2.5¢
Change
-0.001(1.96%)
Mkt cap ! $40.80M
Open High Low Value Volume
2.5¢ 2.5¢ 2.4¢ $147.7K 5.911M

Buyers (Bids)

No. Vol. Price($)
17 1626571 2.4¢
 

Sellers (Offers)

Price($) Vol. No.
2.5¢ 311363 2
View Market Depth
Last trade - 16.10pm 05/09/2025 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.